Also see: Capital One, Intel: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES Amylin Pharmaceuticals ( AMLN) numbers lowered at Goldman. Shares of AMLN now seen reaching $9, according to Goldman Sachs. Estimates also cut, following negative Bydureon data. Sell rating.

Babcock & Wilcox ( BWC) price target higher at Citi to $35 from $32. Outlook for Power improving, Citigroup said. Maintain Hold rating.

CME Group ( CME - Get Report) numbers increased at UBS. CME estimates were raised through 2012, UBS said. Company is seeing higher volues and better pricing. Neutral rating and new $318 price target.

Copart ( CPRT) estimates, target reduced at Goldman. Shares of CPRT now seen reaching $47, according to Goldman Sachs. Estimates also lowered, as the company is facing lower margins. Buy rating.

Dick's Sporting Goods ( DKS - Get Report) numbers raised at Goldman. Shares of DKS now seen reaching $39, according to Goldman Sachs. Estimates also increased, as the company is realizing higher margins. Neutral rating.

Family Dollar ( FDO) price target trimmed at Citi by a dollar to $60. FDO's board adopted poison pill, Citigroup said. Maintain Buy rating.

Foot Locker ( FL - Get Report) price target raised at Citi by a dollar to $25. 4Q10 results show sales are on track, improving margins, Citigroup said. Maintain Buy rating.

Foot Locker ( FL - Get Report) numbers boosted at UBS. Shares of FL now seen reaching $52, according to UBS. Estimates also upped, to match the company's new guidance. Neutral rating.

Frontier Communications ( FTR - Get Report) price target lower at Citi by a dollar to $8. Incremental express overshadowing synergies, Citigroup said. Maintain Hold rating.

HJ Heinz ( HNZ) price target boosted at Citi to $57 from $54. 3Q11 earnings show strong growth in emerging markets with Quero acquisition, Citigroup said. Maintain Buy rating.

Heinz ( HNZ) estimates upped at UBS through 2012, UBS said. Company is seeing some cyclical strength. Neutral rating and $47 price target.

IntercontinentalExchange ( ICE) numbers increased at UBS. Estimates were raised through 2012, UBS said. Company is realizing higher volumes. Buy rating and new $147 price target.

Intermune ( ITMN) estimates, target increased at Goldman. ITMN estimates were raised through 2015, Goldman Sachs said. Esbriet approval will boost growth. Neutral rating and new $42 price target.

Lincoln Education ( LINC) target boosted at Credit Suisse to $15 from $13 on strong 4Q10 results. Strong starts and enrolls, Credit Suisse said. Maintain Neutral rating.

MBIA ( MBI) estimates lowered at UBS through 2012, UBS said. Company is facing higher structured finance losses. Neutral rating and $12 price target.

Marvell Technologies Group ( MRVL) estimates cut at Credit Suisse. MRVL 2011 and 2012 EPS estimates reduced to $1.64 and $1.40, respectively. Earnings shortfall forces lower estimates, Credit Suisse said. Maintain Outperform rating and $22 price target.

Marvell Technology ( MRVL) numbers lowered at Goldman. MRVL estimates were cut through 2013. Company is being hurt by lower PC demand. Neutral rating and new $20 price target.

Teekay Offshore Partners ( TOO) price target higher at Citi to $33 from $31.50. Company agreed to buy remaining equity in OPCO, strategic move, Citigroup said. Maintain Buy rating.

Viacom ( VIA.B) estimates, target raised at UBS. Shares of VIA.B now seen reaching $52, according to UBS. Estimates also increased, given better domestic advertising growth. Buy rating.

Warner Chilcott ( WCRX) estimates increased at UBS through 2012. Refinancing will cut interest expense. Buy rating and $28 price target.

Western Refining ( WNR) price target raised at Credit Suisse to $21.50 from $17. 4Q10 EPS miss, but outlook was positive, Credit Suisse said. Maintain Neutral rating.

This article was written by a staff member of TheStreet.